Recent clinical research targets improved outcomes in vulnerable neonates. Intratracheal budesonide combined with surfactant shows promise for preterm infant lung protection, addressing bronchopulmonary dysplasia. Additionally, studies explore medical staff perspectives on Neurally Adjusted Ventilatory Assist (NAVA) for respiratory distress in extremely low birth weight infants, signaling advances in ventilatory management.